Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials

AIMS/HYPOTHESIS: This study aimed to evaluate the effect of ertugliflozin, a sodium–glucose cotransporter 2 (SGLT2) inhibitor, on eGFR and albuminuria (urine albumin/creatinine ratio [UACR]) vs glimepiride or placebo/glimepiride (non-ertugliflozin) over 104 weeks of treatment in participants with ty...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetologia
Main Authors: Cherney, David Z. I., Heerspink, Hiddo J. L., Frederich, Robert, Maldonado, Mario, Liu, Jie, Pong, Annpey, Xu, Zhi J., Patel, Shrita, Hickman, Anne, Mancuso, James P., Gantz, Ira, Terra, Steven G.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7228910/
https://ncbi.nlm.nih.gov/pubmed/32236732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-020-05133-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker